Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion

Gene Therapy

Volumn 21, Issue 1, 2014, Pages 44-51

  Fischer, G ^a   Pan, B ^a   Vilceanu, D ^a   Hogan, Q H ^a,b   Yu, H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

adeno associated virus; dorsal root ganglion; neuropathic pain; primary sensory neuron; voltage gated calcium channels

Indexed keywords

CALCIUM CHANNEL BINDING DOMAIN 3 PEPTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; PEPTIDE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; DRUG HALF LIFE; MALE; NERVE INJURY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE CELL; SPARED NERVE INJURY; SPINAL GANGLION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENO-ASSOCIATED VIRUS; RATTUS; RODENTIA;

ANALGESICS; ANIMALS; APTAMERS, PEPTIDE; CALCIUM CHANNELS, N-TYPE; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUMBAR VERTEBRAE; MALE; NERVE TISSUE PROTEINS; NEURALGIA; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS;

EID: 84891747283     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.56     Document Type: Article

References (49)

1. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1-32.
2. Park J, Luo ZD. Calcium channel functions in pain processing. Channels (Austin) 2010; 4: 510-517.
3. Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T et al. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2\+ channel. EMBO J 2001; 20: 2349-2356. (Pubitemid 32452852)
4. Saegusa H, Matsuda Y, Tanabe T. Effects of ablation of N-and R-type Ca(2\+) channels on pain transmission. Neurosci Res 2002; 43: 1-7. (Pubitemid 34628578)
5. Pexton T, Moeller-Bertram T, Schilling JM, Wallace MS. Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 2011; 20: 1277-1284.
6. Todorovic SM, Jevtovic-Todorovic V. Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling. Pflugers Arch 2013; 465: 921-927.
7. Chi XX, Schmutzler BS, Brittain JM, Wang Y, Hingtgen CM, Nicol GD et al. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons. J Cell Sci 2009; 122: 4351-4362.
8. Brittain JM, Piekarz AD, Wang Y, Kondo T, Cummins TR, Khanna R. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem 2009; 284: 31375-31390.
9. Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2) channel complex. Nat Med 2011; 17: 822-829.
10. Wilson SM, Brittain JM, Piekarz AD, Ballard CJ, Ripsch MS, Cummins TR et al. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex. Channels (Austin) 2011; 5: 449-456.
11. Piekarz AD, Due MR, Khanna M, Wang B, Ripsch MS, Wang R et al. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Mol Pain 2012; 8: 54.
12. Ripsch MS, Ballard CJ, Khanna M, Hurley JH, White FA, Khanna R. A peptide uncoupling crmp-2 from the presynaptic ca(2\+) channel complex demonstrates efficacy in animal models of migraine and aids therapy-induced neuropathy. Transl Neurosci 2012; 3: 1-8.
13. Sapunar D, Ljubkovic M, Lirk P, McCallum JB, Hogan QH. Distinct membrane effects of spinal nerve ligation on injured and adjacent dorsal root ganglion neurons in rats. Anesthesiology 2005; 103: 360-376. (Pubitemid 41076734)
14. Chung JM, Chung K. Importance of hyperexcitability of DRG neurons in neuropathic pain. Pain Pract 2002; 2: 87-97.
15. Beutler AS. AAV provides an alternative for gene therapy of the peripheral sensory nervous system. Mol Ther 2010; 18: 670-673.
16. Fischer G, Kostic S, Nakai H, Park F, Sapunar D, Yu H et al. Direct injection into the dorsal root ganglion: technical, behavioral, and histological observations. J Neurosci Methods 2011; 199: 43-55.
17. Pfirrmann CW, Oberholzer PA, Zanetti M, Boos N, Trudell DJ, Resnick D et al. Selective nerve root blocks for the treatment of sciatica: evaluation of injection site and effectiveness-a study with patients and cadavers. Radiology 2001; 221: 704-711. (Pubitemid 33101762)
18. Schwartz JJ, Zhang S. Peptide-mediated cellular delivery. Curr Opin Mol Ther 2000; 2: 162-167. (Pubitemid 30212265)
19. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005; 57: 559-577. (Pubitemid 40255561)
20. Tao F, Johns RA. Tat-mediated peptide intervention in analgesia and anesthesia. Drug Dev Res 2010; 71: 99-105.
21. Abedi MR, Caponigro G, Kamb A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res 1998; 26: 623-630. (Pubitemid 28295298)
22. Hoppe-Seyler F, Crnkovic-Mertens I, Tomai E, Butz K. Peptide aptamers: specific inhibitors of protein function. Curr Mol Med 2004; 4: 529-538. (Pubitemid 38961196)
23. Yu H, Fischer G, Ferhatovic L, Fan F, Light AR, Weihrauch D et al. Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats. PLoS One 2013; 8: e61266.
24. McCallum JB, Wu HE, Tang Q, Kwok WM, Hogan QH. Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury. Neuroscience 2011; 179: 244-255.
25. Jagodic MM, Pathirathna S, Joksovic PM, Lee W, Nelson MT, Naik AK et al. Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 2008; 99: 3151-3156.
26. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000; 87: 149-158. (Pubitemid 30621447)
27. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82: 981-1011.
28. Liu XJ, Gingrich JR, Vargas-Caballero M, Dong YN, Sengar A, Beggs S et al. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat Med 2008; 14: 1325-1332.
29. Wilson SM, Schmutzler BS, Brittain JM, Dustrude ET, Ripsch MS, Pellman JJ et al. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2\+ channel peptides. J Biol Chem 2012; 287: 35065-35077.
30. Borghouts C, Kunz C, Groner B. Peptide aptamer libraries. Comb Chem High Throughput Screen 2008; 11: 135-145. (Pubitemid 351347218)
31. Polyakov V, Sharma V, Dahlheimer JL, Pica CM, Luker GD, Piwnica-Worms D. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug Chem 2000; 11: 762-771.
32. Cunha FM, Berti DA, Ferreira ZS, Klitzke CF, Markus RP, Ferro ES. Intracellular peptides as natural regulators of cell signaling. J Biol Chem 2008; 283: 24448-24459.
33. Mason MR, Ehlert EM, Eggers R, Pool CW, Hermening S, Huseinovic A et al. Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol Ther 2010; 18: 715-724.
34. Rycroft BK, Vikman KS, Christie MJ. Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol 2007; 580: 883-894. (Pubitemid 46909040)
35. Cizkova D, Marsala J, Lukacova N, Marsala M, Jergova S, Orendacova J et al. Localization of N-type Ca2\+ channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 2002; 147: 456-463. (Pubitemid 35440498)
36. Matthews EA, Dickenson AH. Effects of spinally delivered N-and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001; 92: 235-246. (Pubitemid 32367955)
37. Yaksh TL. Calcium channels as therapeutic targets in neuropathic pain. J Pain 2006; 7: S13-S30. (Pubitemid 43106684)
38. Schmidtko A, Lotsch J, Freynhagen R, Geisslinger G. Ziconotide for treatment of severe chronic pain. Lancet 2010; 375: 1569-1577.
39. Jacus MO, Uebele VN, Renger JJ, Todorovic SM. Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons. J Neurosci 2012; 32: 9374-9382.
40. Liu X, Zhou JL, Chung K, Chung JM. Ion channels associated with the ectopic discharges generated after segmental spinal nerve injury in the rat. Brain Res 2001; 900: 119-127. (Pubitemid 32452271)
41. Xiao WH, Bennett GJ. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther 1995; 274: 666-672.
42. Nelson MT, Joksovic PM, Perez-Reyes E, Todorovic SM. The endogenous redox agent L-cysteine induces T-type Ca2\+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J Neurosci 2005; 25: 8766-8775. (Pubitemid 41362055)
43. Dubiel SM, Cieslak J, Sturhahn W, Sternik M, Piekarz P, Stankov S et al. Vibrational properties of alpha-and sigma-phase Fe-Cr alloy. Phys Rev Lett 2010; 104: 155503.
44. Ji Y, Li B, Reed TD, Lorenz JN, Kaetzel MA, Dedman JR. Targeted inhibition of Ca2\+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17. J Biol Chem 2003; 278: 25063-25071. (Pubitemid 37548670)
45. Sato AK, Viswanathan M, Kent RB, Wood CR. Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 2006; 17: 638-642. (Pubitemid 44791908)
46. Pertin M, Gosselin RD, Decosterd I. The spared nerve injury model of neuropathic pain. Methods Mol Biol 2012; 851: 205-212.
47. Hogan Q, Sapunar D, Modric-Jednacak K, McCallum JB. Detection of neuropathic pain in a rat model of peripheral nerve injury. Anesthesiology 2004; 101: 476-487. (Pubitemid 38988505)
48. Wu ZZ, Guan BC, Li ZW, Yang Q, Liu CJ, Chen JG. Sustained potentiation by substance P of NMDA-activated current in rat primary sensory neurons. Brain Res 2004; 1010: 117-126. (Pubitemid 38569859)
49. Todorovic SM, Lingle CJ. Pharmacological properties of T-type Ca2\+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 1998; 79: 240-252. (Pubitemid 28133817)